Companies: 10,795·Total market cap: $144.5T
Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc.

XTNTAMEXHealthcare● Active
$0.45
$-0.01(-1.62%)
Market Cap$62907938
P/E Ratio
52W High$0.95
52W Low$0.44
Overview

Xtant Medical Holdings, Inc. (XTNT) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · XTNT · as of Jun 9, 2026

Key Statistics

EPS (TTM)$0.01xtnt eps ttm · xtnt earnings per shareEarnings history
PE Ratio (TTM)34.0×xtnt pe ratio ttm · xtnt price to earningsPE Ratio deep dive
Revenue (TTM)$121.9Mxtnt revenue ttm · xtnt annual revenueFull revenue history
Dividend YieldNo Dividenddoes xtnt pay dividends · xtnt dividend yieldDividend history
Shares Outstanding139.5Mxtnt shares outstanding · xtnt floatShares outstanding history
Next EarningsAug 12, 2026Est.xtnt earnings date · xtnt next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$133.9M▲ +14.21% YoY
202320242025
xtant medical holdings, inc. revenue · xtnt revenue 2025
FY 2025Net Income$5.0M▲ +130.23% YoY
202320242025
xtant medical holdings, inc. net income · xtnt profit 2025
FY 2025EPS$0.04▲ +133.33% YoY
202320242025
xtnt eps · xtant medical holdings, inc. earnings per share 2025
TTM:Revenue: $121.9MNet Income: $1.8MEPS: $0.01View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy5 analystsis xtnt a buy · xtnt analyst rating
Strong Buy
0
Buy
4
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$1.50Low
$0.45Current
$1.50Avg Target234.45% upside
$1.50High
xtnt price target · xtnt 12 month forecast

Total: 5 · Buy rate: 80.0%

The XTNT analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $1.50, representing +234.45% upside from the current price of $0.45.

Stock Performance

Full History
1D-1.62%
1W-2.99%
1M-13.75%
3M-27.66%
YTD-42.79%
1Y-33.06%
5Y-72.65%

About Xtant Medical Holdings, Inc.

CEOSean E. Browne
IPO DateJul 1, 2010
Employees217
CountryUS

Xtant Medical Holdings, Inc. a company based in Belgrade, Montana, specializes in the development, production, and distribution of advanced regenerative medicine products and medical devices. The fir…

what is xtant medical holdings, inc. · xtnt stock overview · xtant medical holdings, inc. company profile · who is xtant medical holdings, inc. ceo · xtnt AMEX · xtant medical holdings, inc. headquarters · xtant medical holdings, inc. business segments

About Stock Overview & Key Data

Xtant Medical Holdings, Inc. (XTNT) is a Healthcare company in the Medical - Devices industry, listed on AMEX since Jul 1, 2010. As of the latest trading session, XTNT stock price is $0.45, with a market capitalization of $62.9M. The stock has returned -33.06% over the past 12 months and -42.79% year-to-date.

According to 5 Wall Street analysts, the consensus rating for Xtant Medical Holdings, Inc. stock is Buy, with an average 12-month price target of $1.50. In fiscal year 2025, Xtant Medical Holdings, Inc. reported revenue of $133.9M and net income of $5.0M. For detailed data — including Xtant Medical Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Xtant Medical Holdings, Inc. (XTNT) stock price is $0.45. The stock is traded on AMEX under the ticker symbol XTNT. The 52-week range is $0.44 – $0.95.

XTNT stock priceXTNT quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice